分析和研究口腔微生物与阿尔茨海默病之间的关系
Alternative therapies in health and medicine
|July 22, 2024
概括
口腔微生物,包括细菌和病毒,可以进入大脑并加剧阿尔茨海默病的进展. 保持口腔卫生和探索菌体治疗等干预措施可能有助于减轻与这种神经退行性疾病相关的风险.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 是老年人常见的一种神经退行性疾病,显著影响生活质量.
- 新出现的证据表明,口腔微生物与阿尔茨海默病的进展之间存在联系.
研究的目的:
- 研究口腔微生物种群与阿尔茨海默氏病的发病过程之间的复杂关系.
主要方法:
- 对口腔微生物种群进行了全面的文献审查.
- 免疫光检测用于检测小鼠大脑皮层中的白蛋白沉积.
- 西方斑点分析评估了小鼠大脑中CYP46A1的表达.
主要成果:
- 口腔微生物 (细菌,病毒,真菌,螺旋虫) 可以突破血脑屏障,导致炎症并加剧AD病理.
- 在大鼠中,Porphyromonas gingivalis bacteremia增加了血脑屏障的透性和白蛋白沉积.
- 在AD小鼠中长期使用SLAB51显示细胞染色体P450 46A1 (CYP46A1) 的表达增加.
结论:
- 口腔卫生干预措施,包括疫苗接种和菌体疗法,对管理口腔感染和潜在地减轻AD进展有希望.
- 保持良好的口腔卫生对于老年人来说至关重要,以减少阿尔茨海默病的风险和影响.
相关概念视频
01:26Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
01:22Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172